Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder

• Status: Completed
• Trial end date: 2006-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to compare pregabalin to Venlafaxine XR and placebo in the treatment of generalized anxiety disorder.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer; Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
• Treatments: Pregabalin; Venlafaxine Hydrochloride

Criteria

Inclusion Criteria:

• Male and female outpatients with diagnosis of generalized anxiety disorder.

Exclusion Criteria:

• Any serious or uncontrolled medical condition.

• Current diagnosis of depression, dysthymia, obsessive-compulsive disorder.